Daily variation in lung function in COPD patients with combined albuterol and ipratropium: Results from a 4-week, randomized, crossover study
Author:
Funder
GlaxoSmithKline
Publisher
Elsevier BV
Subject
Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine
Reference17 articles.
1. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper;Celli;Eur Respir J,2004
2. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease;Global Initiative for Chronic Obstructive Lung Disease (GOLD),2011
3. Reducing cholinergic constriction: the major reversible mechanism in COPD;Brusasco;Eur Respir Rev,2006
4. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial;COMBIVENT Inhalation Aerosol Study Group;Chest,1994
5. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study;Bateman;Eur Respir J,2013
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids;Respiratory Research;2021-07-01
2. Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations: USA Observational Cohort Study Using the Clinformatics™ Health Claims Database;Pulmonary Therapy;2017-04-24
3. Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm;International Journal of Chronic Obstructive Pulmonary Disease;2017-04
4. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2016-09
5. Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility;International Journal of Chronic Obstructive Pulmonary Disease;2016-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3